Publications by authors named "Alexander G Turpie"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

33,738

Total Likes

637

Extended Reach

369,419

Social Features

71
S
Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry.
Paolo Prandoni, Meg Fluharty, Sebastian Schellong, Henri Bounameaux, Sylvia Haas, Alexander Gg Turpie

Eur J Intern Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.
Werner Hacke, Jean-Pierre Bassand, Saverio Virdone, A John Camm, David A Fitzmaurice, Alexander Gg Turpie

Int J Stroke· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.
Sylvia Haas, A John Camm, Jean-Pierre Bassand, Pantep Angchaisuksiri, Frank Cools, Alexander Gg Turpie

Am Heart J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
Sylvia Haas, Hugo Ten Cate, Gabriele Accetta, Pantep Angchaisuksiri, Jean-Pierre Bassand, Alexander G G Turpie

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.
Sylvia Haas, Gerlind Holberg, Reinhold Kreutz, Michael Rud Lassen, Lorenzo Mantovani, Alexander Gg Turpie

Vasc Health Risk Manag· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
A John Camm, Gabriele Accetta, Giuseppe Ambrosio, Dan Atar, Jean-Pierre Bassand, Alexander G G Turpie

Heart· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice.
Jan Beyer-Westendorf, Patrick Mouret, Alexander Gg Turpie

Orthop Res Rev· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design.
Jeffrey I Weitz, Sylvia Haas, Walter Ageno, Pantep Angchaisuksiri, Henri Bounameaux, Alexander G G Turpie

Thromb Haemost· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
Jean-Pierre Bassand, Gabriele Accetta, Alan John Camm, Frank Cools, David A Fitzmaurice, Alexander G G Turpie

Eur Heart J· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.
Craig I Coleman, Sylvia Haas, Alexander G G Turpie, Silvia Kuhls, Susanne Hess

Clin Cardiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on real-world evidence for the treatment of DVT: XALIA.
Walter Ageno, Alexander G G Turpie

Thromb Haemost· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.
David A Fitzmaurice, Gabriele Accetta, Sylvia Haas, Gloria Kayani, Hector Lucas Luciardi, Alexander G G Turpie

Br J Haematol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation.
John M Kittelson, Philippe Gabriel Steg, Jonathan L Halperin, Neil A Goldenberg, Sam Schulman, Alexander G G Turpie

Thromb Haemost· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
A John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Alexander G G Turpie

Eur Heart J· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions.
Reinhold Kreutz, Sylvia Haas, Gerlind Holberg, Michael R Lassen, Lorenzo G Mantovani, Alexander G G Turpie

Br J Clin Pharmacol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life studies and good clinical practice - Authors' reply.
Walter Ageno, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Alexander G G Turpie

Lancet Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice.
Michael R Lassen, Sylvia Haas, Reinhold Kreutz, Lorenzo G Mantovani, Gerlind Holberg, Alexander G G Turpie

Clin Appl Thromb Hemost· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Walter Ageno, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Alexander G G Turpie

Lancet Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014.
Jeffrey I Weitz, William Semchuk, Alexander G G Turpie, William D Fisher, Cindy Kong

Clin Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients.
Louis Kwong, Alexander G G Turpie

Curr Orthop Pract· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation.
A John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Alexander G G Turpie

Vasc Health Risk Manag· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives.
Alexander G G Turpie

Expert Rev Cardiovasc Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis.
Walter Ageno, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Verena Haupt, Alexander Gg Turpie

Thromb J· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation.
Alexander Gg Turpie

Ther Clin Risk Manag· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis